Related Experiment Video
Updated: Jul 10, 2026

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
Published on: June 18, 2016
Platelet activation In mice and human Helicobacter pylori infection
J I Elizalde1, J Gómez, J Panés
1Department of Gastroenterology, Hospital Clínic i Provincial, University of Barcelona, 08036 Barcelona, Spain.
Abstract:
Extracts of Helicobacter pylori (HP) have been shown to induce leukocyte adhesion in mesenteric venules, but the effects of HP infection on gastric microvessels are unknown. Inflammatory cell interactions in the gastric microcirculation were studied by intravital videomicroscopy in mice inoculated with either saline or fresh isolates of HP. Platelet aggregates were detected and quantified in murine portal blood, while endothelial P-selectin expression was determined using the dual radiolabeled mAb technique. Platelet activation and aggregation were studied in HP-infected patients and controls by measuring the platelet-aggregate ratio and platelet P-selectin expression. HP infection induced a marked increase in the flux of rolling leukocytes and the appearance of platelet and leukocyte- platelet aggregates in murine gastric venules. The HP-induced rolling and platelet aggregate formation was abrogated by mAbs against L- or P-, but not E- selectin. Endothelial cell expression of P-selectin was not altered, but platelet P-selectin expression was enhanced in HP-infected mice. Circulating platelet aggregates and activated platelets were also detected in HP-infected patients. These findings indicate that platelet activation and aggregation contribute to the microvascular dysfunction and inflammatory cell recruitment associated with HP infections.
Insights
Helicobacter pylori (HP) infection causes platelet activation and aggregation, leading to inflammatory cell recruitment in gastric microvessels. This platelet activity contributes to microvascular dysfunction during HP infections.
Area of Science:
- Gastroenterology
- Immunology
- Microcirculation Research
Background:
- Helicobacter pylori (HP) infection is a significant cause of gastritis and peptic ulcers.
- Previous studies showed HP extracts induce leukocyte adhesion in mesenteric venules.
- The impact of HP infection on gastric microvessels remained unclear.
Purpose of the Study:
- To investigate the effects of HP infection on gastric microcirculation.
- To determine the role of inflammatory cell interactions and platelet activation in HP-associated gastric pathology.
Main Methods:
- Intravital videomicroscopy in HP-inoculated mice to study gastric microcirculation.
- Quantification of platelet aggregates in portal blood.
- Measurement of endothelial and platelet P-selectin expression.
- Assessment of platelet-aggregate ratio and platelet activation markers in HP-infected patients.
Main Results:
- HP infection significantly increased leukocyte rolling and the formation of platelet-leukocyte aggregates in gastric venules.
- HP-induced rolling and platelet aggregation were blocked by antibodies against L- and P-selectin.
- Platelet P-selectin expression was enhanced in HP-infected mice and patients, indicating platelet activation.
- Circulating platelet aggregates and activated platelets were observed in HP-infected patients.
Conclusions:
- Platelet activation and aggregation are key mechanisms in HP infection.
- These platelet changes contribute to microvascular dysfunction and inflammatory cell recruitment in the gastric microcirculation.
- Targeting platelet activation may offer therapeutic strategies for HP-related gastrointestinal issues.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer
Gastritis II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology

